Viktor Berge

2.9k total citations
58 papers, 1.9k citations indexed

About

Viktor Berge is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Viktor Berge has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Viktor Berge's work include Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (26 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Viktor Berge is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (30 papers), Prostate Cancer Treatment and Research (26 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Viktor Berge collaborates with scholars based in Norway, United Kingdom and Germany. Viktor Berge's co-authors include Alicia Llorente, Kirsten Sandvig, Tore Skotland, Aud Svindland, Therese Seierstad, Dimple Kauhanen, Kim Ekroos, Helena Simolin, Lars Magne Eri and Ingrid Jenny Guldvik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Viktor Berge

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Berge Norway 21 1.1k 685 666 179 173 58 1.9k
Jonas Busch Germany 26 1.0k 0.9× 1.1k 1.7× 716 1.1× 158 0.9× 53 0.3× 109 2.2k
Timo Piironen Finland 29 424 0.4× 1.6k 2.3× 374 0.6× 336 1.9× 133 0.8× 50 2.3k
Alessandro Gentilucci Italy 21 473 0.4× 954 1.4× 331 0.5× 358 2.0× 98 0.6× 71 1.7k
Raymond S. Lance United States 24 864 0.8× 1.4k 2.1× 509 0.8× 195 1.1× 256 1.5× 51 2.6k
Ronald Tutrone United States 21 426 0.4× 1.1k 1.6× 398 0.6× 273 1.5× 74 0.4× 111 1.7k
Masayuki Takahashi Japan 26 1.3k 1.2× 1.2k 1.7× 715 1.1× 60 0.3× 119 0.7× 114 2.3k
Peter F.A. Mulders Netherlands 22 567 0.5× 1.5k 2.2× 584 0.9× 175 1.0× 38 0.2× 43 1.9k
Daphne Hessels Netherlands 23 1.7k 1.5× 2.3k 3.4× 1.5k 2.2× 269 1.5× 52 0.3× 48 3.5k
Koji Mitsuzuka Japan 22 424 0.4× 761 1.1× 214 0.3× 143 0.8× 86 0.5× 117 1.5k
Christian Wülfing Germany 22 629 0.6× 786 1.1× 356 0.5× 63 0.4× 99 0.6× 113 1.9k

Countries citing papers authored by Viktor Berge

Since Specialization
Citations

This map shows the geographic impact of Viktor Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Berge more than expected).

Fields of papers citing papers by Viktor Berge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Berge. The network helps show where Viktor Berge may publish in the future.

Co-authorship network of co-authors of Viktor Berge

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Berge. A scholar is included among the top collaborators of Viktor Berge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Berge. Viktor Berge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Støer, Nathalie C., et al.. (2022). Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. BMC Cancer. 22(1). 1301–1301. 4 indexed citations
3.
Berge, Viktor, et al.. (2021). Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. British Journal of Cancer. 126(3). 492–501. 24 indexed citations
4.
Berge, Viktor, et al.. (2021). Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens. European Urology Open Science. 26. 55–63. 9 indexed citations
5.
6.
Fosså, Sophie D., Rune Kvåle, Bjørn Møller, et al.. (2018). Is time from diagnosis to radical prostatectomy associated with oncological outcomes?. World Journal of Urology. 37(8). 1571–1580. 14 indexed citations
7.
Axcrona, Karol, Rune Kvåle, Bjørn Møller, et al.. (2017). Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway. Urology. 110. 140–147. 8 indexed citations
8.
Giskeødegård, Guro F., Elise Sandsmark, Helena Bertilsson, et al.. (2017). Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. 117(11). 1656–1664. 36 indexed citations
9.
Skotland, Tore, Kim Ekroos, Dimple Kauhanen, et al.. (2016). Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. European Journal of Cancer. 70. 122–132. 279 indexed citations
10.
Wang, Ling, Tore Skotland, Viktor Berge, Kirsten Sandvig, & Alicia Llorente. (2016). Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation. European Journal of Pharmaceutical Sciences. 98. 80–85. 76 indexed citations
11.
Rud, Erik, Eduard Baco, Dagmar Klotz, et al.. (2015). Does Preoperative Magnetic Resonance Imaging Reduce the Rate of Positive Surgical Margins at Radical Prostatectomy in a Randomised Clinical Trial?. European Urology. 68(3). 487–496. 44 indexed citations
12.
Ahmed, Hashim U., Viktor Berge, David Bottomley, et al.. (2014). Can we deliver randomized trials of focal therapy in prostate cancer?. Nature Reviews Clinical Oncology. 11(8). 482–491. 47 indexed citations
13.
Itkonen, Harri M., Sarah Minner, Ingrid Jenny Guldvik, et al.. (2013). O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells. Cancer Research. 73(16). 5277–5287. 243 indexed citations
14.
15.
Eri, Lars Magne, et al.. (2002). Comparative study of pressure‐flow parameters. Neurourology and Urodynamics. 21(3). 186–193. 12 indexed citations
16.
17.
Berge, Viktor, Knut Erik Berge, & Egil Johnson. (1996). Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro. Apmis. 104(7-8). 523–530. 2 indexed citations
18.
Johnson, Egil, Viktor Berge, & Kolbjørn Högåsen. (1994). Formation of the Terminal Complement Complex on Agarose Beads: Further Evidence that Vitronectin (Complement S‐Protein) Inhibits C9 Polymerization. Scandinavian Journal of Immunology. 39(3). 281–285. 10 indexed citations
19.
20.
Berge, Viktor, et al.. (1992). Human Umbilical Vein Endothelial Cells Synthesize S‐Protein (Vitronectin) In Vitro. Scandinavian Journal of Immunology. 36(1). 119–124. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Busch Breakdown of academic impact, for papers by Timo Piironen Breakdown of academic impact, for papers by Alessandro Gentilucci Breakdown of academic impact, for papers by Raymond S. Lance Breakdown of academic impact, for papers by Ronald Tutrone Breakdown of academic impact, for papers by Masayuki Takahashi Breakdown of academic impact, for papers by Peter F.A. Mulders Breakdown of academic impact, for papers by Daphne Hessels Breakdown of academic impact, for papers by Koji Mitsuzuka Breakdown of academic impact, for papers by Christian Wülfing
Rankless by CCL
2026